Robinul and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Robinul (glycopyrrolate), especially for people who are male, 60+ old, also take Coumadin, and have Diabetes.

The phase IV clinical study analyzes which people have Stroke when taking Robinul. It is created by eHealthMe based on reports of 1,584 people who have side effects when taking Robinul from the FDA, and is updated regularly.

What is Robinul?

Robinul has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 1,663 Robinul users. Check the latest studies of Robinul.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,322 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jun, 26, 2026

1,584 people reported to have side effects when taking Robinul.
Among them, 21 people (1.33%) have Stroke.

Among these 21 people:

What is the gender of people who have Stroke when taking Robinul? *

female: 38.1 %
male: 61.9 %

What is the age of people who have Stroke when taking Robinul? *

What are other drugs people take besides Robinul? *

What are other side effects people have besides Stroke? *

Weight Decreased: 10 people, 47.62%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 8 people, 38.10%
Pain: 7 people, 33.33%
Upper Respiratory Tract Infection: 6 people, 28.57%
Stress And Anxiety: 6 people, 28.57%
Fall: 6 people, 28.57%
Fatigue (feeling of tiredness): 5 people, 23.81%
Diarrhea: 5 people, 23.81%
Speech Impairment (Adult) (inability to speak (adult)): 5 people, 23.81%
Weight Increased: 4 people, 19.05%

What are the existing conditions these people have? *

Pain: 4 people, 19.05%
High Blood Pressure: 4 people, 19.05%
Diabetes: 4 people, 19.05%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 14.29%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 14.29%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 9.52%
Asthma: 2 people, 9.52%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 4.76%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 4.76%
High Blood Cholesterol: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Robinul and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Robinul:

Robinul (1,663 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Robinul:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,322 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Robinul) and Robinul (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.